Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C

BACKGROUND/AIMS: Thyroid dysfunction (TD) is more likely to occur in patients with chronic hepatitis C (CHC) and is particularly associated with interferon (IFN) treatment. The purpose of this study was to investigate the incidence, outcomes, and risk factors for TD during pegylated interferon (PEG-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Yong, Kim, Won, Kwon, So Young, Yu, Hyung Min, Kim, Jeong Han, Choe, Won Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642008/
https://www.ncbi.nlm.nih.gov/pubmed/26552454
http://dx.doi.org/10.3904/kjim.2015.30.6.792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642008/
https://www.ncbi.nlm.nih.gov/pubmed/26552454
http://dx.doi.org/10.3904/kjim.2015.30.6.792

Ejemplares similares